Despite robust fundamentals, Cintas trades at a premium valuation. Click here to find out why I am neutral on CTAS stock.

Italy's Eni and Argentina's YPF signed an agreement to develop the Argentina liquefied natural gas export project, ...

The U.S. Supreme Court on Friday allowed the Department of Government Efficiency ((DOGE)) access to the social security ...

HIO offers an attractive 11% yield, but its focus on high-yield, below-investment-grade debt increases risk. Click here to ...

Despite a recent earnings miss, Blue Owl Capital's revenue and AUM growth remain stellar, and future earnings should rebound.

Palantir's DoD contracts, strong Q1 2025 growth, and competitive edge in AI-driven platforms make it a standout growth ...

Pure Cycle is a patient, long-term investment; monetizing water assets and real estate will take time. Click here to find out ...

Sunstone Hotel Investors, Inc., a stable REIT offers preferred shares with 7%+ yields. Click for my look at SHO and see if ...

Explore REGENXBIO's RGX-121 gene therapy for Hunter syndrome, with an FDA decision due Nov 9, 2025. Click here to read my ...

The backlog for contract oil driller Valaris remains strong. Read why recent share buybacks signal management’s confidence ...

Kestra Medical Technologies, Ltd. sees sales growth but struggles with losses and slowing revenue. Click for risks tied to ...

Babcock & Wilcox Enterprises, Inc. is addressing debt and boosting orders amidst execution risks. Click for more on BW stock ...